StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis YoY Growth in the U.S. by Quarter

YoY Growth in the U.S. (% USD / cc) (%)

QuarterlyAnnual

Novartis YoY Growth in the U.S.: 9.0% in Q3 2026, up 8.0 pts from a year earlier.

Latest, Q3 2026
9.0%
Period ended Sep 30, 2026
Change on a year earlier
+8.0 pts
1.0% in Q3 2025
History
32 quarters
Since Q4 2018
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Cosentyx | Immunology | Psoriasis (PsO), ankylosing spondylitis (AS), psoriatic arthritis (PsA), non-radiographic axial spondyloarthritis (nr-axSPA), hidradenitis suppurativa (HS) | 1 093 | 9 | 764 | 10 | 9 | 1 857 | 9 | 9”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedYoY Growth in the U.S. (% USD / cc) (%)Year on yearSource
Q3 2026Sep 30, 20269.0%+8.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202616.0%+10.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-6.0%-29.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20259.0%-27.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20251.0%-37.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20256.0%-28.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202523.0%-2.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202436.0%+19.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202438.0%+41.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202434.0%+46.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202425.0%+45.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202317.0%+35.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023-3.0%-2.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023-12.0%-15.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023-20.0%-22.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-18.0%-30.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis YoY Growth in the U.S. (%), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-cosentyx-us-yoy-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.